CMS
Massachusetts Jury Indicts Healthcare Providers in $7.8M Lab Kickback Scheme
According to the government, these providers submitted false claims to MassHealth for urine drug tests and home health services.
Guardant Health's Shield Colorectal Cancer Blood Test Garners CMS Advanced Diagnostic Status
The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.
Healthcare Providers, Lab Marketers Pay $1.9M to Resolve Fraud Charges
According to the government, lab marketing firms arranged with healthcare providers to steer test referrals to a South Carolina lab in exchange for kickbacks.
California Lab Operator Convicted of $4M Urine Testing Lab Fraud Scheme
Sherif Khalil, the operator of Gardena, California-based Spectra Clinical Labs defrauded Medicare by paying kickbacks for medically unnecessary test orders.
Natera MRD Test Receives MolDx Coverage for Lung Cancer Surveillance
The test has met coverage requirements for use with patients with non-small cell lung cancer with resectable or unresectable disease in the surveillance setting.